HK/China Healthcare Analyst (ex-Fosun Pharma)

Xinyao (Criss) Wang

Equity Capital Markets

Acrobiosystems   / Equity Capital Markets

<ul>
<li>ACROBIOSYSTEMS's technological and quality advantages lie in its focus on the development of highly complex recombinant proteins. But the product structure remains relatively homogenous, so diversification needs to be improved.</li>
<li>Based on the positive YoY growth of net profit in 25Q1-Q3, we think that the turning point of performance has emerged, and the future growth trend is clear.</li>
<li>The liquidity of the Hong Kong stock market is lower than the A-share market. We think if ACROBIOSYSTEMS A-shares are taken as the benchmark, the discount could be 20%-40%.</li>
</ul>


ACROBIOSYSTEMS's technological and quality advantages lie in its focus on the development of highly complex recombinant proteins. But the product structure remains relatively homogenous, so diversification needs to be improved.
Based on the positive YoY growth of net profit in 25Q1-Q3, we think that the turning point of performance has emerged, and the future growth trend is clear.
The liquidity of the Hong Kong stock market is lower than the A-share market. We think if ACROBIOSYSTEMS A-shares are taken as the benchmark, the discount could be 20%-40%.


Pre-IPO Acrobiosystems (A/H Listing) - The Business and the Outlook

China

Acrobiosystems Co. Ltd. develops and manufactures biomedical products. The Company produces recombinant proteins and other critical reagents. Acrobiosystems focuses on product design, quality control, and solution based support businesses.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Acrobiosystems (301080 CH)

Pre-IPO Acrobiosystems (A/H Listing) - The Business and the Outlook

ACROBIOSYSTEMS focus on recombinant proteins but needs to diversify product structure. Positive YoY growth suggests a performance turning...

Xinyao (Criss) Wang

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)

Pre-IPO Acrobiosystems (A/H Listing) - The Business and the Outlook

​ACROBIOSYSTEMS focus on recombinant proteins but needs to diversify product structure. Positive YoY growth suggests a performance turning...

Xinyao (Criss) Wang

ACROBIOSYSTEMS focus on recombinant proteins but needs to diversify product structure. Positive YoY growth suggests a performance turning...